Ventripoint Diagnostics Ltd. (TSXV:VPT)

Market Cap	23.88M +12.5%
Revenue (ttm)	179.93K +89.1%
Net Income	-3.20M
EPS	-0.02
Shares Out	191.02M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.1250
Previous Close	0.1250
Day's Range	0.1150 - 0.1250
52-Week Range	0.0800 - 0.1900
Beta	-0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 5, 2026

About Ventripoint Diagnostics

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. It also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, in...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Hugh MacNaught
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: VPT

Financial Performance

In 2025, Ventripoint Diagnostics's revenue was 179,928, an increase of 89.06% compared to the previous year's 95,172. Losses were -3.20 million, -34.95% less than in 2024.